Trial · NCT01549964
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 24-Week Treatment Period | STARTED | Placebo | 132 | |
| 24-Week Treatment Period | STARTED | Sitagliptin 100 mg | 260 | |
| 24-Week Treatment Period | STARTED | Fasiglifam 25 mg | 263 | |
| 24-Week Treatment Period | STARTED | Fasiglifam 50 mg | 261 | |
| 24-Week Treatment Period | Safety Analysis Set=Received Treatment | Placebo | 132 | |
| 24-Week Treatment Period | Safety Analysis Set=Received Treatment | Sitagliptin 100 mg | 260 | |
| 24-Week Treatment Period | Safety Analysis Set=Received Treatment | Fasiglifam 25 mg | 263 | |
| 24-Week Treatment Period | Safety Analysis Set=Received Treatment | Fasiglifam 50 mg | 260 | |
| 24-Week Treatment Period | COMPLETED | Placebo | 71 | |
| 24-Week Treatment Period | COMPLETED | Sitagliptin 100 mg | 149 | |
| 24-Week Treatment Period | COMPLETED | Fasiglifam 25 mg | 147 | |
| 24-Week Treatment Period | COMPLETED | Fasiglifam 50 mg | 140 | |
| 24-Week Treatment Period | NOT COMPLETED | Placebo | 61 | |
| 24-Week Treatment Period | NOT COMPLETED | Sitagliptin 100 mg | 111 | |
| 24-Week Treatment Period | NOT COMPLETED | Fasiglifam 25 mg | 116 | |
| 24-Week Treatment Period | NOT COMPLETED | Fasiglifam 50 mg | 121 | |
| 80-Week Extension Period | STARTED | Placebo | 66 | |
| 80-Week Extension Period | STARTED | Sitagliptin 100 mg | 138 | |
| 80-Week Extension Period | STARTED | Fasiglifam 25 mg | 140 | |
| 80-Week Extension Period | STARTED | Fasiglifam 50 mg | 137 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01549964/flow